GB201909466D0 - Compounds for treating cancer - Google Patents
Compounds for treating cancerInfo
- Publication number
- GB201909466D0 GB201909466D0 GBGB1909466.3A GB201909466A GB201909466D0 GB 201909466 D0 GB201909466 D0 GB 201909466D0 GB 201909466 A GB201909466 A GB 201909466A GB 201909466 D0 GB201909466 D0 GB 201909466D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treating cancer
- cancer
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909466.3A GB201909466D0 (en) | 2019-07-01 | 2019-07-01 | Compounds for treating cancer |
| PCT/GB2020/051583 WO2021001651A1 (en) | 2019-07-01 | 2020-07-01 | Hdac inhibitors for use in the therapy of biliary tract cancers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909466.3A GB201909466D0 (en) | 2019-07-01 | 2019-07-01 | Compounds for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201909466D0 true GB201909466D0 (en) | 2019-08-14 |
Family
ID=67540166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1909466.3A Ceased GB201909466D0 (en) | 2019-07-01 | 2019-07-01 | Compounds for treating cancer |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201909466D0 (en) |
| WO (1) | WO2021001651A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024131727A1 (en) * | 2022-12-19 | 2024-06-27 | 正大天晴药业集团股份有限公司 | Use of sultam compound in treating biliary tract cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2911856A1 (en) * | 2013-05-10 | 2014-11-13 | Karus Therapeutics Ltd | Tri-substituted amino hydroxamate compounds and pharmaceutical compositions thereof for use as histone deacetylase inhibitors |
| GB201609786D0 (en) * | 2016-06-03 | 2016-07-20 | Karus Therapeutics Ltd | Compounds and method of use |
| US11998546B2 (en) * | 2016-10-28 | 2024-06-04 | Acetylon Pharmaceuticals, Inc. | Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereof |
| TW201912183A (en) * | 2017-08-31 | 2019-04-01 | 德商４Ｓｃ製藥公司 | Hdac inhibitor in combination with antimetabolite agent for cancer therapy |
-
2019
- 2019-07-01 GB GBGB1909466.3A patent/GB201909466D0/en not_active Ceased
-
2020
- 2020-07-01 WO PCT/GB2020/051583 patent/WO2021001651A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021001651A1 (en) | 2021-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287907A (en) | Methods for treating cancer | |
| IL304275A (en) | Methods for treating cancer | |
| IL312680A (en) | Methods for treating cancer | |
| IL277861A (en) | Axl-specific antibodies for cancer treatment | |
| GB201903546D0 (en) | Cancer treatment | |
| EP3892282A4 (en) | Combination for treating cancer | |
| GB201709405D0 (en) | Compounds for treating ovarian cancer | |
| IL282093A (en) | Combination therapy for cancer | |
| IL287652A (en) | Cancer treatment | |
| IL289213A (en) | Pharmaceutical composition for treating tumor | |
| IL292136A (en) | Vector for cancer treatment | |
| SG11202010528XA (en) | Combinations for treating cancer | |
| IL288135A (en) | Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating notch-activated breast cancer | |
| IL287593B (en) | Multivalent pd-l1 binding compounds for treating cancer | |
| IL285466A (en) | Cancer treatment | |
| GB201909468D0 (en) | Compounds for treating cancer | |
| EP3962919A4 (en) | Compounds for treating cancer | |
| IL289201A (en) | Compounds for treatment of cancer | |
| EP3296294A4 (en) | Compound for treating or preventing breast cancer | |
| IL290319A (en) | Compound for combination treatment | |
| PL4048284T4 (en) | Method for treating cancers | |
| GB201918313D0 (en) | Cells for treating cancer | |
| GB201909466D0 (en) | Compounds for treating cancer | |
| IL286680A (en) | Medicament for treating cancer | |
| PL3630754T3 (en) | Isoindoline-acetylene compounds for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |